Phase I-II study of MDV3100 in castration resistant prostate cancer. The Prostate Cancer Clinical Trials consortium Meeting Abstract
| Authors: | Scher, H.; Beer, T.; Higano, C.; Logothetis, C.; Shelkey, J.; Hung, D.; Hirmand, M.; Larson, S.; Fleisher, M.; Sawyers, C. |
| Abstract Title: | Phase I-II study of MDV3100 in castration resistant prostate cancer. The Prostate Cancer Clinical Trials consortium |
| Meeting Title: | 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Journal Title: | EJC Supplements |
| Volume: | 6 |
| Issue: | 12 |
| Meeting Dates: | 2008 Oct 21-24 |
| Meeting Location: | Geneva, Switzerland |
| ISSN: | 1359-6349 |
| Publisher: | Pergamon-Elsevier Science Ltd |
| Date Published: | 2008-10-01 |
| Start Page: | 51 |
| End Page: | 52 |
| Language: | English |
| ACCESSION: | WOS:000261221200158 |
| DOI: | 10.1016/s1359-6349(08)72092-5 |
| PROVIDER: | wos |
| Notes: | --- - Meeting Abstract: 160 - Poster - 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - OCT 21-24, 2008 - Geneva, SWITZERLAND - "Source: Wos" |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work